Stock Events

Novo Nordisk 

€113.16
52
-€1.72-1.5% Today

Statistics

Day High
114.5
Day Low
112.5
52W High
-
52W Low
-
Volume
3,859
Avg. Volume
-
Mkt Cap
-
P/E Ratio
-
Dividend Yield
1.45%
Dividend
1.64

Upcoming

Dividends

1.45%Dividend Yield
10Y Growth
N/A
5Y Growth
8.12%
3Y Growth
8.63%
1Y Growth
26.48%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NOV.F. It's not an investment recommendation.

About

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Show more...
CEO
Mr. Lars Fruergaard Jorgensen
Employees
63370
Country
DK
ISIN
DK0062498333
WKN
000A3EU6F

Listings